Rhonda Farnum - Feb 28, 2022 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, COMM & MEDICAL AFFAIRS
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Stock symbol
TBPH
Transactions as of
Feb 28, 2022
Transactions value $
-$23,947
Form type
4
Date filed
3/2/2022, 06:08 PM
Previous filing
Feb 23, 2022
Next filing
May 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Sale -$23.9K -2.36K -0.7% $10.16 333K Feb 28, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 5/17/21.
F2 This transaction was executed in multiple trades at prices from $10.02 to $10.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.